Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

Share Price is delayed by 15 minutes
Get Live Data
16.75    0.00 (0.00%)
Bid:
16.00
Ask:
17.50
Spread: 1.50 (9.375%)
Market Cap: £11.07m
ESYS Live PriceLast checked at - London Stock Exchange

Intraday Essensys Share Chart

Form 8.3 Essensys PLC

4 Dec 2025 15:27

RNS Number : 3372K
William Currie Investments Limited
04 December 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

William Currie and

William Currie Investments Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Essensys PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

03/12/25

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,326,891

3.59%

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

2,326,891

3.59%

 

 

 

 

 

 

 

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

04/12/25

Contact name:

Jackie Mottram

Telephone number*:

01512363809

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEASALEALSFFA
Date   Source Headline
1st Jun 202612:27 pmRNSResult of General Meeting
29th May 20262:26 pmRNSHolding(s) in Company
14th May 20267:00 amRNSPosting of circular and notice of general meeting
14th May 20267:00 amRNSCompulsory Acquisition and Closure of Offer
11th May 20266:11 pmRNSHolding(s) in Company
11th May 20267:00 amRNSProposed cancellation of admission to trading
8th May 20266:00 pmRNSEssensys
8th May 20265:38 pmRNSExercise of Options and Total Voting Rights
8th May 20267:45 amRNSDisclosure Table
8th May 20267:00 amRNSOffer Declared Unconditional
7th May 20261:18 pmRNSForm 8.3 - Essensys Plc
7th May 20268:51 amRNSForm 8.5 (EPT/RI)
7th May 20267:00 amRNSDay 58 Acceptance Level Update
6th May 20267:00 amRNSDay 57 Acceptance Level Update
5th May 20267:00 amRNSDay 56 acceptance level update
30th Apr 202611:04 amRNSForm 8.3 - Essensys Plc
30th Apr 20269:55 amRNSForm 8.5 (EPT/RI)
28th Apr 20264:13 pmRNSForm 8.3 - Essensys PLC
28th Apr 20267:00 amRNSAcceptance Level Update
22nd Apr 202611:14 amRNSForm 8.3 - Essensys Plc
22nd Apr 202610:26 amRNSForm 8.5 (EPT/RI)
21st Apr 202611:36 amRNSForm 8.3 - Essensys PLC
21st Apr 202610:41 amRNSForm 8.5 (EPT/RI)
21st Apr 20267:00 amRNSDay 42 acceptance level update
17th Apr 202611:36 amRNSForm 8.3 - Essensys Plc
17th Apr 20267:00 amRNSHalf year results
14th Apr 20267:00 amRNSDay 35 acceptance level update
7th Apr 20267:00 amRNSDay 28 Acceptance Level Update
31st Mar 20267:00 amRNSDay 21 Acceptance Level Update
30th Mar 202612:15 pmRNSForm 8.3 - Essensys Plc
23rd Mar 20261:07 pmRNSForm 8.3 - Essensys Plc
19th Mar 20264:54 pmRNSExercise of Options, Total Voting Rights - Replace
18th Mar 20265:04 pmRNSExercise of Options, Total Voting Rights
11th Mar 202610:55 amRNSForm 8.3 - Essensys Plc
9th Mar 20263:35 pmRNSPublication of Offer Document
4th Mar 20261:48 pmRNSForm 8.3 - Essensys PLC
3rd Mar 20266:01 pmRNSForm 8.3 - Essensys plc
2nd Mar 20265:16 pmRNSForm 8.3 - essensys PLC
2nd Mar 20263:07 pmRNSForm 8.3 - Essensys plc
2nd Mar 20262:09 pmRNSForm 8.3 - Essenys Group Ltd
2nd Mar 202610:23 amRNSForm 8.5 (EPT/RI)
27th Feb 20265:54 pmRNSForm 8.3 - Essensys Plc
27th Feb 20265:24 pmRNSHolding(s) in Company
27th Feb 20263:54 pmRNSForm 8.3 - essensys plc
26th Feb 20262:54 pmRNSForm 8.3 - Essenys PLC
26th Feb 202612:30 pmRNSForm 8.3 - essensys plc
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 202610:16 amRNSForm 8.5 (EPT/RI)
25th Feb 20264:13 pmRNSForm 8.3 - Essensys plc
25th Feb 20262:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.